HLS Therapeutics (HLS) News Today C$4.66 +0.14 (+3.10%) As of 03:18 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Research Analysts Set Expectations for TSE:HLS Q1 EarningsHLS Therapeutics Inc. (TSE:HLS - Free Report) - Analysts at Stifel Canada issued their Q1 2025 earnings estimates for HLS Therapeutics in a research note issued to investors on Tuesday, March 25th. Stifel Canada analyst J. Keywood expects that the company will earn ($0.16) per share for the quartMarch 28 at 6:00 AM | marketbeat.comStifel Nicolaus Issues Positive Forecast for HLS Therapeutics (TSE:HLS) Stock PriceStifel Nicolaus increased their target price on HLS Therapeutics from C$3.50 to C$4.00 and gave the company a "hold" rating in a research report on Wednesday.March 27 at 2:06 PM | marketbeat.comHLS Therapeutics (TSE:HLS) Price Target Raised to C$4.00 at Stifel NicolausMarch 27 at 3:01 AM | americanbankingnews.comHLS Therapeutics (TSE:HLS) Stock Price Down 1.2% - Here's WhyHLS Therapeutics (TSE:HLS) Stock Price Down 1.2% - Here's WhyMarch 15, 2025 | marketbeat.comHLS Therapeutics Inc (HLS) Receives a Hold from Stifel NicolausMarch 14, 2025 | markets.businessinsider.comHLS Therapeutics Appoints Christine Elliott to its Board of DirectorsMarch 13, 2025 | finance.yahoo.comHLS Therapeutics Gets Green Light for Share Buyback ProgramMarch 13, 2025 | marketwatch.comHLS Therapeutics (TSE:HLS) Trading Down 1.2% - Here's What HappenedHLS Therapeutics (TSE:HLS) Shares Down 1.2% - Here's WhyFebruary 20, 2025 | marketbeat.comTop Canadian Pharmaceutical Stocks of 2025February 3, 2025 | fool.caHLS Therapeutics (TSE:HLS) Shares Down 1.5% - Here's WhyHLS Therapeutics (TSE:HLS) Shares Down 1.5% - Should You Sell?January 29, 2025 | marketbeat.comHLS Therapeutics (TSE:HLS) Stock Price Down 1.8% - What's Next?HLS Therapeutics (TSE:HLS) Trading Down 1.8% - Here's What HappenedJanuary 7, 2025 | marketbeat.comHLS Therapeutics (TSE:HLS) Shares Down 0.3% - What's Next?HLS Therapeutics (TSE:HLS) Stock Price Down 0.3% - Time to Sell?December 14, 2024 | marketbeat.comRaymond James Boosts HLS Therapeutics (TSE:HLS) Price Target to C$5.00Raymond James raised their target price on shares of HLS Therapeutics from C$4.00 to C$5.00 in a research note on Friday.November 22, 2024 | marketbeat.comStifel Canada Forecasts Weaker Earnings for HLS TherapeuticsHLS Therapeutics Inc. (TSE:HLS - Free Report) - Equities research analysts at Stifel Canada decreased their FY2024 EPS estimates for HLS Therapeutics in a research report issued on Tuesday, November 12th. Stifel Canada analyst J. Keywood now expects that the company will earn ($0.88) per share foNovember 15, 2024 | marketbeat.comOptimistic Buy Rating for HLS Therapeutics Despite Revenue ChallengesNovember 10, 2024 | markets.businessinsider.comHLS Therapeutics Third Quarter 2024 Earnings: Misses ExpectationsNovember 8, 2024 | finance.yahoo.comHLS Therapeutics Inc (HLTRF) Q3 2024 Earnings Call Highlights: Strategic Debt Reduction and ...November 8, 2024 | finance.yahoo.comHLS Therapeutics Inc (TSX:HLS) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 6, 2024 | finance.yahoo.comHLS Therapeutics (HLS) Set to Announce Earnings on ThursdayHLS Therapeutics (TSE:HLS) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.October 31, 2024 | marketbeat.comHLS Therapeutics (TSE:HLS) Hits New 1-Year Low - What's Next?HLS Therapeutics (TSE:HLS) Reaches New 1-Year Low - Here's WhyOctober 25, 2024 | marketbeat.comHLS Therapeutics Inc. (TSE:HLS) Shares Could Be 38% Below Their Intrinsic Value EstimateOctober 17, 2024 | finance.yahoo.comDantech Announces Participation as a Silver Sponsor at BioFuture 2024 in New York CityOctober 14, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Stock Price Down 4.3% - Time to Sell?HLS Therapeutics (TSE:HLS) Trading Down 4.3% - Here's What HappenedOctober 10, 2024 | marketbeat.comHLS Therapeutics Inc (HLTRF) Q2 2024 Earnings Call Highlights: Strategic Growth Amid Revenue ...October 9, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Trading Down 0.6%HLS Therapeutics (TSE:HLS) Shares Down 0.6%September 18, 2024 | marketbeat.comHLS Therapeutics to Present at H.C. Wainwright's 26th Annual Global Investment ConferenceAugust 28, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Reaches New 12-Month Low at $3.00HLS Therapeutics (TSE:HLS) Hits New 1-Year Low at $3.00August 26, 2024 | marketbeat.comHLS Therapeutics Inc. (74D.F)August 23, 2024 | finance.yahoo.comHLS Therapeutics Inc. (TSE:HLS) to Post Q3 2024 Earnings of ($0.19) Per Share, Stifel Canada ForecastsHLS Therapeutics Inc. (TSE:HLS - Free Report) - Research analysts at Stifel Canada boosted their Q3 2024 EPS estimates for HLS Therapeutics in a research note issued to investors on Monday, August 12th. Stifel Canada analyst J. Keywood now expects that the company will post earnings of ($0.19) peAugust 15, 2024 | marketbeat.comHLS Therapeutics (TSE:HLS) Given New C$3.25 Price Target at Stifel NicolausStifel Nicolaus lowered their target price on HLS Therapeutics from C$3.75 to C$3.25 in a research note on Tuesday.August 13, 2024 | marketbeat.comFDA gives thumbs down to MDMA for now, demanding further researchAugust 13, 2024 | msn.comHLS Therapeutics Inc. to Post Q3 2024 Earnings of ($0.21) Per Share, Raymond James Forecasts (TSE:HLS)HLS Therapeutics Inc. (TSE:HLS - Free Report) - Analysts at Raymond James upped their Q3 2024 earnings per share (EPS) estimates for HLS Therapeutics in a research report issued on Thursday, August 8th. Raymond James analyst R. Sarugaser now anticipates that the company will post earnings per shaAugust 12, 2024 | marketbeat.comHLS Therapeutics Announces Q2 2024 Financial ResultsAugust 8, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Hits New 12-Month Low at $3.02HLS Therapeutics (TSE:HLS) Sets New 12-Month Low at $3.02August 2, 2024 | marketbeat.comAmarin Corporation plc (NASDAQ:AMRN) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | msn.comHLS Therapeutics (HLS) Scheduled to Post Quarterly Earnings on ThursdayHLS Therapeutics (TSE:HLS) will be releasing earnings before the market opens on Thursday, August 8, Zacks reports.August 1, 2024 | marketbeat.comAmarin Plc (AMRN) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | msn.comHLS Announces Reimbursement for Vascepa® under Alberta's Provincial Drug PlanJuly 29, 2024 | finance.yahoo.comFTSE 100 LIVE: European stocks slump after Wall Street suffers worst sell-off in over a yearJuly 25, 2024 | sg.finance.yahoo.comHLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference CallJuly 25, 2024 | ca.finance.yahoo.comHLS Therapeutics (TSE:HLS) Reaches New 12-Month Low at $3.07HLS Therapeutics (TSE:HLS) Reaches New 1-Year Low at $3.07July 24, 2024 | marketbeat.comClosing Bell: Hls Therapeutics Inc flat on Wednesday (HLS)July 19, 2024 | theglobeandmail.comHLS Therapeutics (TSE:HLS) Hits New 12-Month Low at $3.25HLS Therapeutics (TSE:HLS) Hits New 52-Week Low at $3.25July 2, 2024 | marketbeat.comHLS Therapeutics (TSE:HLS) Sets New 52-Week Low at $3.26HLS Therapeutics (TSE:HLS) Reaches New 1-Year Low at $3.26June 17, 2024 | marketbeat.comNew Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine TreatmentMay 28, 2024 | finance.yahoo.comRaymond James Lowers HLS Therapeutics (TSE:HLS) Price Target to C$4.00Raymond James reduced their price objective on shares of HLS Therapeutics from C$5.00 to C$4.00 in a research note on Friday.May 10, 2024 | marketbeat.comHLS Therapeutics Inc HLSMay 9, 2024 | morningstar.comHLS Therapeutics Announces Q1 2024 Financial ResultsMay 9, 2024 | finance.yahoo.comHLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 9, 2024 | finance.yahoo.comNew REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsApril 8, 2024 | finance.yahoo.com Remove Ads Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. Email Address HLS Media Mentions By Week HLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HLS News Sentiment▼1.120.78▲Average Medical News Sentiment HLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HLS Articles This Week▼61▲HLS Articles Average Week Remove Ads Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aurora Cannabis News Today Canopy Growth News Today Cipher Pharmaceuticals News Today Organigram News Today Cardiol Therapeutics News Today BioSyent News Today SugarBud Craft Growers News Today Medexus Pharmaceuticals News Today MediPharm Labs News Today Decibel Cannabis News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:HLS) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredRevealed: The Chip Stock Redefining AI as We Know ItIn this urgent presentation, Wall Street's so-called "AI Oracle" unveils the name of a small American tech fir...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HLS Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
